As Michigan cannabis prices fall, business owners point to other threats to their survival
The business owners and other industry stakeholders who spoke during the 1½-hour-long meeting, held both in-person in Lansing and virtually, called for more effective enforcement and regulatory reform to stabilize the industry.
Their comments come as the price of marijuana flower continues to decline — dropping to its lowest level of $65.21 for an ounce of recreational marijuana flower in February — making it hard for businesses to make a profit. Cannabis companies that use undisclosed substances in their products to save money can undercut the prices of other sellers, making it tougher for businesses to compete, industry stakeholders said.
At the same time, a new tax on marijuana products, recently proposed by Gov. Gretchen Whitmer to fund Michigan roads, adds to obstacles for business owners. A cannabis attorney called that proposal a "very serious and existential threat" at the meeting.
Some of the concerns raised at the meeting on Wednesday include:
Lindsay Feehan, who spoke in person and identified herself as one of the owners of Lansing-based Emerald Transport, said the fact that the average retail price for an ounce of recreational marijuana flower has dropped to $65.21 is a bad thing for everyone in the industry, including transporters.
"We are all losing," Feehan said. "I don't know who you could tell me is winning on that."
Recreational marijuana prices drop again in Michigan: What it means for the industry
A caller who identified himself as Eric Colandrea and an attorney for LaHaze Cannabis Co., a grower and processor in Cheboygan, said fines resulting from enforcement actions taken by the CRA are based on rules that are poorly written and are "arbitrary."
"When you layer on the various licensing fees that we pay annually in the high $75,000 range, adding on an extra $9,000 in fines for something that really could have been a warning or could have been a $500 fine, it hurts," Colandrea said. "Right now, there's millions of dollars invested in our facility and given the pricing that we're getting for the product, we're not making money. We're losing money. So if we don't have some actions by the agency that make sense when it comes to fines, you're just going to drive these businesses like us out ... and blow up a lot of investments and put a lot of people out of work."
A caller who identified as David Bye with the Michigan for Safe Cannabis Coalition said conversion oil (oil that's synthetically converted into THC, which is the psychoactive component of the marijuana plant), unregulated hemp-derived products and illegal cannabis "still undermine the integrity of our regulated market" in which companies are required to follow state rules.
"Despite clear violations, a significant number of license holders caught with large quantities of illegal products still retain their licenses and are still doing business today," Bye said. "Obviously, we know that's very unsettling, and we're looking for ways to resolve that."
The CRA has said that it intends to make clear in a new rule set proposed by the CRA in 2023 that CBD to THC conversion is prohibited in Michigan.
More on these undisclosed substances: Michigan cannabis lab CEO says hidden substances could taint vape pens, edibles
A few industry stakeholders brought up Whitmer's plan to raise $470 million per year for roads by imposing a 32% wholesale tax on marijuana, which they said would result in business closures because consumers wouldn't be willing to pay higher prices for cannabis products and would turn to the illicit market.
Matt Imig, who spoke in person representing Lansing-based M&M Agriculture, described the proposed tax as dropping "a bombshell" on the industry.
"What are people going to do," Imig asked at the meeting. "Where is it going to go? Are we starting to look at what the possible loopholes are for people? ... Maybe small growers are going to get stuck and then you could just kiss the small businesses goodbye. Maybe that's the goal: to just have 10 or 15 huge players and the rest of the small mom-and-pop shops just go away."
Contact Adrienne Roberts: amroberts@freepress.com.
This article originally appeared on Detroit Free Press: Michigan cannabis businesses warn of real threats they face
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
27 minutes ago
- Business Insider
$5.3 billion Abridge wants to make acquisitions. Here's what the healthcare AI startup is looking for.
Abridge is on a hot streak. Now, as the healthcare startup competes in the AI talent wars, it's preparing to go on a shopping spree. Abridge, which builds AI-powered software to transcribe and summarize patient-doctor conversations, landed a $300 million round in June led by Andreessen Horowitz. It was its second mega-raise in four months; the company had raked in a $250 million round in February. In 18 months, Abridge has raised $700 million in total and boosted its valuation from $850 million to $5.3 billion. Abridge CEO and cofounder Dr. Shiv Rao has big plans for all of that capital, he told Business Insider. "We've got a lot of money in the bank, and we want to spend 80% of it just going deeper, and expanding from connecting conversations to clinical notes into claims, clinical decision support, and care management," he said. With 80% of its cash reserved for doubling down on its tech, Abridge is earmarking the remaining 20% for potential acquisitions, Rao said. Those deals are looking increasingly critical in the brutal, competitive landscape of ambient healthcare scribes. Perhaps the most gutting release is set to come from Epic, the electronic health record giant that first partnered with Abridge back in 2023 in a watershed moment for the startup. Epic is now gearing up to launch an AI scribe of its own, Politico reported this month. Abridge declined to comment on the reports. Epic didn't respond to requests for comment. Epic's launch would follow healthcare startup Ambience, Abridge's biggest direct competitor, raising its own mega-round this summer. Ambience's $250 million Series C was co-led by Oak HC/FT and A16z, a longtime investor in Ambience that appears to be double-dipping in AI scribing with its growth investment in Abridge. And, as Abridge works to expand beyond scribing to use AI for tasks like processing medical bills, it's running up against private equity firms like New Mountain Capital pouring billions into their healthcare AI plays. Abridge has remained a frontrunner as the pressure builds. It's now working with over 150 large health systems, Rao said. The startup is also partnering closely with some of those health systems on its new products — Abridge said Tuesday it's collaborating with Pittsburgh health system Highmark Health on tech to automate prior authorization requests. And Abridge is focusing squarely on the patient-provider conversation as the starting point for each of its new tools or acquisition targets, Rao said. "The last thing we want to do is to become a company that's opening up a trench coat and selling you random things that have no coherence to our mission," he said. "But if there are things that are absolutely on our road map, it would be smart for us to have open ears." Eyeing fresh talent and tech As San Francisco-based Abridge has landed fundraise after fundraise, many startups hoping to get acquired by Abridge have entered Rao's inbox. While Rao said Abridge isn't "in talks" with any particular company, it's prepared to notch deals to grow faster. The startup hasn't made any acquisitions since its 2018 founding. "It feels like a lot of companies are asking if they can join us in some way. We need to be able to spend on things like that — data plays, ecosystem plays, and partnerships," Rao said. Acquiring top talent is Abridge's biggest priority, Rao said, adding that the startup has been competing with AI giants like OpenAI and Anthropic in its recent hiring efforts. The AI talent wars are raising the stakes for startups like Abridge. As Big Tech companies fight over top AI researchers, including by offering pay packages in the millions or tens of millions, startups are touting their mission-centric approaches to convince engineers to join their teams over tech giants. Rao thinks Abridge can compete effectively for AI talent by offering hires the rare chance to build tools that matter, tech that actually improves people's health. "Finding ways to recruit more world-class talent as fast as possible is really, really important for us," he said. "If this is the legacy you want to leave, if you want to be a part of a company where every single day you can feel really good that you improved patient care, then we're going to resonate more than those horizontal technology companies." Abridge has about 330 employees, a number Rao is aiming to increase massively, especially in its engineering department, though he says the company won't rely exclusively on M&A to do that. Abridge builds its own large-language models that its widening suite of software sits upon. Those models make up its "contextual reasoning engine," which automates clinical notetaking that can combine ambient scribing with relevant context from the patient's existing health records and generate actionable outputs like medical orders and suggested billing codes. Rao said Abridge is considering buying data where necessary to continue training its models. With a combination build-and-buy strategy, Abridge is moving further into revenue cycle management, the hottest ticket item in healthcare AI, since it aims to help health systems capture more revenue while saving time for doctors. Rao said Abridge is also working on areas like risk adjustment, the process of estimating a patient's expected medical costs, that is critical for value-based care arrangements, and care coordination. Abridge wants to dig deeper into clinical decision support, too, a field that many healthcare startups have stayed away from, as the tech often walks a thin line to avoid facing FDA regulations. Abridge first stepped into the space in October by partnering with medical insights company UpToDate to surface relevant clinical evidence in Abridge's generated notes. Rao said he expects Abridge to share more information from the partnership later this year. As Abridge looks to take over more tasks for doctors, the company is being deliberate about how and when it'll meet "good friction" like FDA regulation, Rao said. "As we move into higher-stakes workflows from a patient outcomes perspective, we have to be really, really responsible," he said. "We try to be as transparent as we possibly can on how our models work and how we evaluate them. We'll need to continue to be transparent as we get into those new spaces."
Business Insider
27 minutes ago
- Business Insider
NetBox Labs raised $35 million amid an AI-driven infrastructure boom. See the pitch deck it used to land its Series B funding.
New York City-based NetBox Labs was cofounded in 2023 by CEO Kris Beevers as the for-profit steward of 10-year-old NetBox, an open-source network and infrastructure platform used by tens of thousands of companies globally. NetBox Labs offers five products built on top of the open-source software with advanced features to make it easier to run, Beevers said, including additional security and support, automation tools, and an AI assistant. It makes money by charging subscriptions based on the tools used and the size of a client's infrastructure. Sorenson Capital and Headline participated in the round, as did existing investors Flybridge Capital, Notable Capital, Mango Capital, Salesforce Ventures, Two Sigma Ventures, and IBM. The company had previously raised $20 million in Series A funding. AI is fueling demand for infrastructure services, and NetBox Labs' revenue is in the single-digit millions, Beevers said. It reinvests a "big chunk" back into the open-source tool. The company has roughly 200 customers, including AI data center giant CoreWeave, for whom it helps manage data center configurations and design future facilities. It also works with non-AI-focused companies, whose infrastructure has become more complex and dynamic amid ongoing digitization in recent years, Beevers said. This includes departments of transportation across the country — managing toll booths, speed cameras, and more— as well as ARM, Cisco, Constant Contact, J.P. Morgan, Kaiser Permanente, and Riot Games. The investment will be used to hire across engineering and sales. Beevers said the company will surpass 100 employees this year. Beevers previously served as the cofounder and CEO of NS1, which spun out NetBox Labs after selling the other part of its business to IBM in 2023. Jeremy Stretch, the creator of NetBox, also serves as a cofounder at NetBox Labs. Here's a look at the pitch deck the startup used to raise its $35 million Series B. Certain slides have been edited and removed so that the deck can be shared publicly. Network and Infrastructure Management Is Growing More Painful, Exponentially NetBox = Leverage to Massive Platform Play NetBox Wins in an AI World
Business Insider
an hour ago
- Business Insider
NetBox Labs raised $35 million amid an AI-driven infrastructure boom. See the pitch deck it used to land its Series B funding.
NetBox Labs, an infrastructure management startup, raised $35 million in Series B funding in July, led by NGP Capital. It shared its pitch deck with Business Insider. New York City-based NetBox Labs was cofounded in 2023 by CEO Kris Beevers as the for-profit steward of 10-year-old NetBox, an open-source network and infrastructure platform used by tens of thousands of companies globally. NetBox Labs offers five products built on top of the open-source software with advanced features to make it easier to run, Beevers said, including additional security and support, automation tools, and an AI assistant. It makes money by charging subscriptions based on the tools used and the size of a client's infrastructure. Sorenson Capital and Headline participated in the round, as did existing investors Flybridge Capital, Notable Capital, Mango Capital, Salesforce Ventures, Two Sigma Ventures, and IBM. The company had previously raised $20 million in Series A funding. AI is fueling demand for infrastructure services, and NetBox Labs' revenue is in the single-digit millions, Beevers said. It reinvests a "big chunk" back into the open-source tool. The company has roughly 200 customers, including AI data center giant CoreWeave, for whom it helps manage data center configurations and design future facilities. It also works with non-AI-focused companies, whose infrastructure has become more complex and dynamic amid ongoing digitization in recent years, Beevers said. This includes departments of transportation across the country — managing toll booths, speed cameras, and more— as well as ARM, Cisco, Constant Contact, J.P. Morgan, Kaiser Permanente, and Riot Games. The investment will be used to hire across engineering and sales. Beevers said the company will surpass 100 employees this year. Beevers previously served as the cofounder and CEO of NS1, which spun out NetBox Labs after selling the other part of its business to IBM in 2023. Jeremy Stretch, the creator of NetBox, also serves as a cofounder at NetBox Labs. Here's a look at the pitch deck the startup used to raise its $35 million Series B. Certain slides have been edited and removed so that the deck can be shared publicly. NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs NetBox Labs
